| アブストラクト | OBJECTIVES: Develop an endometrial cancer risk prediction model and externally validate it for UK primary care use. DESIGN: Cohort study. SETTING: The UK Biobank was used for model development and a linked primary (Clinical Practice Research Datalink, CPRD) and secondary care (HES), mortality (ONS) and cancer register (NRCAS) dataset was used for external validation. POPULATION: Women aged 45-60 years with no history of endometrial cancer or hysterectomy. METHODS: Model development was performed using a flexible parametric survival model and stepwise backward selection aiming to minimise the Akaike information criterion. Model performance on external validation was assessed through flexible calibration plots, calculation of the expected to observed ratio and C-statistic and decision curve analysis. MAIN OUTCOME MEASURES: Endometrial cancer diagnosis within 1-10 years of the index date. RESULTS: Model development included 222 031 women (902 incident endometrial cancer cases) and external validation 3 094 371 women (8585 endometrial cancer cases). The final model (with equation provided) incorporated age, body mass index, waist circumference, age at menarche, menopause and last birth, hormone replacement, tamoxifen and oral contraceptive pill use, type 2 diabetes, smoking and family history of bowel cancer. It was well calibrated on external validation (calibration slope 1.14, 95% confidence interval [CI] 1.11-1.17, E/O 1.03, 95% CI 1.01-1.05), with moderate/good discrimination (C-statistic 0.70, 95% CI 0.69-0.70) and had improved net benefit compared with previously developed models. CONCLUSIONS: The Predicting risk of endometrial cancer in asymptomatic women model (PRECISION), using easily measurable anthropometric, reproductive, personal and family history, accurately quantifies a woman's 10-year risk of endometrial cancer. Its use could determine eligibility for primary endometrial cancer prevention trials and for targeted resource allocation in UK general practices. |
|---|
| ジャーナル名 | BJOG : an international journal of obstetrics and gynaecology |
|---|
| Pubmed追加日 | 2023/12/11 |
|---|
| 投稿者 | Kitson, Sarah J; Crosbie, Emma J; Evans, D Gareth; Lophatananon, Aritaya; Muir, Kenneth R; Ashcroft, Darren; Kontopantelis, Evan; Martin, Glen P |
|---|
| 組織名 | Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University;of Manchester, Manchester, UK.;Department of Obstetrics and Gynaecology, Manchester University NHS Foundation;Trust, Manchester Academic Health Science Centre, Manchester, UK.;Genomic Medicine, Division of Evolution Infection and Genomic Sciences,;University of Manchester, Manchester, UK.;Division of Population Health, Health Services Research and Primary Care,;Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health,;NIHR Greater Manchester Patient Safety Translational Research Centre (PSTRC),;Division of Informatics, Imaging and Data Science, Faculty of Biology, Medicine;and Health, University of Manchester, Manchester, UK. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/38073256/ |
|---|
